STOCK TITAN

RxSight (RXST) COO exercises stock options, now holding over 79,000 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

RxSight, Inc. Chief Operating Officer Ilya Goldshleger exercised stock options to acquire 12,489 shares of common stock at $4.13 per share. Following the transactions, he holds 78,180 shares directly and 1,372 shares indirectly through his spouse, indicating a routine compensation-related equity exercise with no open-market buying or selling disclosed.

Positive

  • None.

Negative

  • None.
Insider Goldshleger Ilya
Role Chief Operating Officer
Type Security Shares Price Value
Exercise Stock Option (right to buy) 12,489 $0.00 --
Exercise Common Stock 12,489 $4.13 $52K
holding Common Stock -- -- --
Holdings After Transaction: Stock Option (right to buy) — 5 shares (Direct, null); Common Stock — 78,180 shares (Direct, null); Common Stock — 1,372 shares (Indirect, By spouse)
Footnotes (1)
Options exercised 12,489 shares Common stock acquired via option exercise on April 17, 2026
Exercise price $4.13 per share Stock option (right to buy) conversion price
Direct holdings after exercise 78,180 shares Common stock directly owned after April 17, 2026 transactions
Indirect holdings (spouse) 1,372 shares Common stock indirectly owned by spouse
Remaining option position 5 option shares Stock Option (right to buy) after exercise
Option expiration date April 25, 2027 Expiration of Stock Option (right to buy)
Stock Option (right to buy) financial
"security_title: "Stock Option (right to buy)""
derivative exercise/conversion financial
"transaction_action: "derivative exercise/conversion""
indirect ownership financial
"ownership_type: "indirect" and nature_of_ownership: "By spouse""
Common Stock financial
"security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Goldshleger Ilya

(Last)(First)(Middle)
C/O RXSIGHT, INC.
100 COLUMBIA

(Street)
ALISO VIEJO CALIFORNIA 92656

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
RxSight, Inc. [ RXST ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Operating Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/17/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/17/2026M12,489A$4.1378,180D
Common Stock1,372IBy spouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$4.1304/17/2026M12,48904/26/202104/25/2027Common Stock12,489$05D
Explanation of Responses:
/s/ Jim Schindler, as Attorney-in-Fact04/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider activity did RxSight (RXST) report for COO Ilya Goldshleger?

RxSight reported that COO Ilya Goldshleger exercised stock options to acquire 12,489 shares of common stock at $4.13 per share. After these transactions, he directly owns 78,180 shares and indirectly holds 1,372 shares through his spouse.

Did the RxSight (RXST) COO buy or sell shares on the open market?

The filing shows an option exercise, not an open-market trade. Goldshleger exercised stock options to receive 12,489 common shares at a $4.13 exercise price, with no separate reported open-market purchases or sales in this Form 4.

How many RxSight (RXST) shares does the COO own after this Form 4 filing?

After the reported transactions, COO Ilya Goldshleger directly owns 78,180 shares of RxSight common stock. The filing also reports an additional 1,372 shares held indirectly, attributed to his spouse, reflecting both direct and indirect ownership positions.

What stock option position remains for the RxSight (RXST) COO after the exercise?

The Form 4 shows a stock option labeled “right to buy” where 12,489 underlying shares were exercised, leaving 5 option shares outstanding. The option carries a $4.13 exercise price and an expiration date of April 25, 2027.

How is the spouse’s ownership reported in the RxSight (RXST) Form 4?

The filing lists 1,372 RxSight common shares as indirectly owned “by spouse.” This indicates those shares are attributed to COO Ilya Goldshleger through his spouse’s holdings, and they are reported separately from his 78,180 directly owned shares.